Monoclonal Gammopathy of Undetermined Significance
- 1 December 2022
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (12) , ITC177-ITC192
Abstract
Monoclonal gammopathy of undetermined significance (MGUS) is of considerable clinical importance to primary care physicians given its high prevalence in the general population. MGUS has a variable ...Keywords
This publication has 50 references indexed in Scilit:
- Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based studyBlood, 2011
- Prevalence of Monoclonal Gammopathy of Undetermined Significance: A Systematic ReviewMayo Clinic Proceedings, 2010
- Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complicationsBlood, 2010
- Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white womenBlood, 2010
- Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based studyBlood, 2010
- Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort studyThe Lancet, 2010
- Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significanceBlood, 2009
- Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health StudyBlood, 2009
- Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple MyelomaNew England Journal of Medicine, 2007
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004